|
|
-Review-
Changes in Metamorphopsia in Patients Undergoing Treatment for Vitreoretinal Disorders
Department of Ophthalmology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan
Purpose: To quantify and compare the severity of metamorphopsia in patients undergoing vitrectomy for vitreoretinal disorders.
Methods: Data were collected evaluated from 319 patients with vitreoretinal disorders, including epiretinal membrane (ERM), macular hole (MH), cystoid macular edema with branch retinal vein occlusion (BRVO-CME), CME with central retinal vein occlusion (CRVO), diabetic macular edema (DME), macula-off rhegmatogenous retinal detachment (M-off RD), and macula-on RD (M-on RD). Metamorphopsia was recorded with the M-CHARTS preoperatively and at 3 and 6 months postoperatively.
Results: Preoperative and 6-month postoperative metamorphopsia scores were 0.69 ± 0.50 and 0.50 ± 0.52, respectively. Before surgery, 94% of patients presented with metamorphopsia (score ≥0.2). Preoperative metamorphopsia scores were significantly correlated with postoperative metamorphopsia scores (r = 0.378, p < 0.0001). Preoperative metamorphopsia score was significantly higher for ERM (0.89) than for DME (0.51). Vitrectomy significantly improved metamorphopsia in ERM and MH but not in the other disorders. In contrast, treatment improved visual acuity for all disorders except CRVO-CME and M-on RD.
Conclusion: This quantitative study indicated that metamorphopsia is present in most patients undergoing surgery for vitreoretinal diseases and is most severe in ERM. In these patients, vitrectomy improved visual acuity but not metamorphopsia.
J Nippon Med Sch 2024; 91: 28-36
Keywords
metamorphopsia, vitrectomy, retinal disorders
Correspondence to
Fumiki Okamoto, MD, Department of Ophthalmology, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan
f-okamoto@nms.ac.jp
Received, September 2, 2023
Accepted, October 25, 2023
PDF (339K)